Ogle GWFGGAMJ. https://diabetesatlas.org/idfawp/resource-files/2022/12/IDF-T1D-Index-Report.pdf. 2022 [cited 2025 Mar 9]. pp. 1–15 Type 1 diabetes estimates in children and adults. Available from: https://diabetesatlas.org/idfawp/resource-files/2022/12/IDF-T1D-Index-Report.pdf

Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet. 2018;392(10146):477–86. https://doi.org/10.1016/S0140-6736(18)31506-X.

Article  PubMed  PubMed Central  Google Scholar 

Svane J, Lynge TH, Pedersen-Bjergaard U, et al. Cause-specific mortality in children and young adults with diabetes mellitus: a Danish nationwide cohort study. Eur J Prev Cardiol. 2021;28(2):159–65. https://doi.org/10.1177/2047487319836550.

Article  PubMed  Google Scholar 

Bjornstad P, Donaghue KC, Maahs DM, Lancet Publishing Group. Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment? Lancet Diabetes Endocrinol. 2018;6:809–20. https://doi.org/10.1016/S2213-8587(18)30035-4.

Article  PubMed  PubMed Central  Google Scholar 

Harjutsalo V, Barlovic DP, Gordin D, et al. Presence and determinants of cardiovascular disease and mortality in individuals with type 1 diabetes of long duration: the finn diane 50 years of diabetes study. Diabetes Care. 2021;44(8):1885–93. https://doi.org/10.2337/dc20-2816.

Article  CAS  PubMed  Google Scholar 

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Risk factors for cardiovascular disease in type 1 diabetes. Diabetes. 2016;65(5):1370–9. https://doi.org/10.2337/db15-1517.

Article  CAS  Google Scholar 

Rawshani A, Rawshani A, Franzén S, et al. Range of risk factor levels: control, mortality, and cardiovascular outcomes in type 1 diabetes mellitus. Circulation. 2017;135(16):1522–31. https://doi.org/10.1161/CIRCULATIONAHA.116.025961.

Article  PubMed  PubMed Central  Google Scholar 

Guy J, Ogden L, Wadwa RP, Hamman RF, et al. Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for diabetes in youth case-control study. Diabetes Care. 2009;32(3):416–20. https://doi.org/10.2337/dc08-1775.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vergès B. Dyslipidemia in type 1 diabetes: a masked danger. Trends Endocrinol Metab. 2020;31(6):422–34. https://doi.org/10.1016/j.tem.2020.01.015.

Article  CAS  PubMed  Google Scholar 

Shah VN, Grimsmann JM, Foster NC, et al. Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany/Austria) registries. Diabetes Obes Metab. 2020;22(9):1577–85. https://doi.org/10.1111/dom.14069.

Article  CAS  PubMed  Google Scholar 

Lyons SK, Boyle CT, DeSalvo DJ, Rickels MR, Wood Heickman LK, Miller KM, et al. Dyslipidaemia and Statin use in individuals aged 10 to < 40 years in the T1D exchange clinic registry. Diabetes Obes Metab. 2019;21(1):170–2. https://doi.org/10.1111/dom.13475.

Article  CAS  PubMed  Google Scholar 

Society CC, European Association for the Study of Diabetes, and the Latin American Academy for the Study of Lipids and Cardiometabolic Risk, Patel SB, Belalcazar LM, Afreen S et al. American association of clinical endocrinology consensus statement: algorithm for management of adults with dyslipidemia – 2025 update. Endocr Pract 2025 Sep 14:S1530–X891(25)00972–3. https://doi.org/10.1016/j.eprac.2025.07.014

Mach F, Koskinas KC, van Roeters JE, ESC/EAS Scientific Document Group, et al. Focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2025 Aug. 2025;29:ehaf190. https://doi.org/10.1093/eurheartj/ehaf190.

Article  CAS  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ 2021; 372: n71 https://doi.org/10.1136/bmj

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, PCNA Guideline on the Management of Blood Cholesterol. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285–350. https://doi.org/10.1016/j.jacc.2018.11.003

Mourad Ouzzani H, Hammady Z, Fedorowicz, Ahmed Elmagarmid. Rayyan — a web and mobile app for systematic reviews. Syst Reviews. 2016;5:210. https://doi.org/10.1186/s13643-016-0384-4.

Article  Google Scholar 

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.

Article  PubMed  Google Scholar 

Higgins JPT, Li T, Sterne JAC,Chapter 23: Implementing the RoB 2 tool to assess risk of bias in randomized trials. In:, Higgins JPT, Thomas J, Chandler J, et al. editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Version of RoB 2 for crossover trials (2021), available at: https://www.riskofbias.info/welcome/rob-2-0-tool/archive-of-rob-2-0-versions

Schünemann H, Brożek J, Guyatt G, Oxman A. (2013). Manual GRADE para calificar la calidad de la evidencia y la fuerza de la recomendación (1ª Ed. en español). P.A Orrego & M.X. Rojas (Trans.) Mar 2017. available at: http://gdt.guidelinedevelopment.org/app/handbook/handbook.html

GRADEpro GDT. GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from gradepro.org.

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8(1):16.

Article  PubMed  PubMed Central  Google Scholar 

R Core Team. (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/

Hero C, Rawshani A, Svensson AM, Franzén S, Eliasson B, Eeg-Olofsson K, et al. Association between use of lipid-lowering therapy and cardiovascular diseases and death in individuals with type 1 diabetes. Diabetes Care. 2016;39(6):996–1003. https://doi.org/10.2337/dc15-2450.

Article  CAS  PubMed  Google Scholar 

Yoo J, Jeon J, Baek M, Song SO, Kim J. Impact of statin treatment on cardiovascular risk in patients with type 1 diabetes: a population-based cohort study. J Transl Med. 2023;21(1):806. https://doi.org/10.1186/s12967-023-04691-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jialal I, Miguelino E, Griffen SC, Devaraj S. Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes. J Clin Endocrinol Metab. 2007;92(8):3136–40. https://doi.org/10.1210/jc.2007-0453.

Article  CAS  PubMed  Google Scholar 

Konduracka E, Galicka-Latala D, Cieslik G, Rostoff P, Fedak D, Sieradzki J, et al. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension. Diabetes Obes Metab. 2008;10(9):719–25. https://doi.org/10.1111/j.1463-1326.2007.00798.x.

Article  CAS  PubMed  Google Scholar 

Martin S, Herder C, Schloot NC, Koenig W, Heise T, Heinemann L, Kolb H, DIATOR Study Group. Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the randomized DIATOR trial. PLoS ONE. 2011;6(3):e17554. https://doi.org/10.1371/journal.pone.0017554.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krebs A, Doerfer J, Krause A, Grulich-Henn J, Holder M, Hecker W, et al. Lipoprotein-associated phospholipase A2 activity and low-density lipoprotein subfractions after a 2-year treatment with Atorvastatin in adolescents with type 1 diabetes. J Pediatr Endocrinol Metab. 2016;29(10):1181–6. https://doi.org/10.1515/jpem-2015-0365.

Article  CAS  PubMed  Google Scholar 

Marcovecchio ML, Chiesa ST, Bond S, Daneman D, Dawson S, Donaghue KC, et al. ACE inhibitors and Statins in adolescents with type 1 diabetes. N Engl J Med. 2017;377(18):1733–45. https://doi.org/10.1056/NEJMoa1703518.

Article  CAS  PubMed  Google Scholar 

Badreldeen A, El Razaky O, Erfan A, El-Bendary A, El Amrousy D. Comparative study of the efficacy of captopril, simvastatin, and L-carnitine as cardioprotective drugs in children with type 1 diabetes mellitus: a randomised controlled trial. Cardiol Young. 2021;31(8):1315–22. https://doi.org/10.1017/S1047951121000226.

Article  PubMed  Google Scholar 

Fried LF, Forrest KY, Ellis D, Chang Y, Silvers N, Orchard TJ. Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes. J Diabetes Complications. 2001 May-Jun;15(3):113–9. https://doi.org/10.1016/s1056-8727(01)00140-4.

Canas JA, Ross JL, Taboada MV, Sikes KM, Damaso LC, Hossain J, Caulfield MP, Gidding SS, Mauras N. A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of Atorvastatin in children with elevated low-density lipoprotein cholesterol (LDL-C) and type 1 diabetes. Pediatr Diabetes. 2015;16(2):79–89. https://doi.org/10.1111/pedi.12245.

Article  CAS  PubMed  Google Scholar 

Haller MJ, Stein JM, Shuster JJ, Theriaque D, Samyn MM, Pepine C, et al. Pediatric Atorvastatin in diabetes trial (PADIT): a pilot study to determine the effect of Atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2009;22(1):65–8. https://doi.org/10.1515/jpem.2009.22.1.65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cholesterol Treatment Trialists’ (CTT) Collaborators, Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Pet